The cardiovascular system can be monitored and its functionality assessed with cardiovascular magnetic resonance (CMR) imaging. New techniques for CMR imaging have been developed in recent years.
CMR parametric mapping has the potential to improve the assessment and management of Duchenne muscular dystrophy (DMD). Comprehensive CMR parametric mapping may allow healthcare teams to better ...
On Thursday, Tempus AI, Inc. (NASDAQ:TEM) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The update ...
Tempus AI has gained federal clearance for its updated cardiac imaging platform Tempus Pixel. The U.S. Food & Drug Administration's 510(k) FEA approval allows the generation of T1 and T2 inline maps, ...
Cardiovascular disease due to atherosclerosis is the leading cause of disease and mortality worldwide. So-called “vulnerable” atherosclerotic plaques are those that are likely to result in clinical ...